Showing results (4681-4690 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|September 9, 2022
Comprehensive Landscape of Cyclin Pathway Gene Alterations and Co-occurrence with FGF/FGFR Aberrations Across Urinary Tract TumorsDenis L F Jardim, Sherri Z Millis, Jeffrey S Ross, et al.
The Oncologist|September 6, 2022
Plasma Exosomal AKR1C3 mRNA Expression Is a Predictive and Prognostic Biomarker in Patients with Metastatic Castration-Resistant Prostate CancerSha Zhu, Yuchao Ni, Zilin Wang, et al.
The Oncologist|February 8, 2021
Avelumab, a PD-L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple MyelomaDickran Kazandjian, Alexander Dew, Elizabeth Hill, et al.
The Oncologist|February 10, 2021
Cervical Cancer in Sub-Saharan Africa: A Multinational Population-Based Cohort Study of Care and Guideline AdherenceMirko Griesel, Tobias P Seraphin, Nikolaus C S Mezger, et al.
The Oncologist|February 17, 2021
Measuring Ovarian Escape in Premenopausal Estrogen Receptor-Positive Breast Cancer Patients on Ovarian Suppression TherapyEthan Burns, Emre Koca, Jiaqiong Xu, et al.
The Oncologist|February 17, 2021
Randomized, Double-Blind, Placebo-Controlled Phase II Study of Yeast-Brachyury Vaccine (GI-6301) in Combination with Standard-of-Care Radiotherapy in Locally Advanced, Unresectable ChordomaPeter Joseph DeMaria, Marijo Bilusic, Deric M Park, et al.
The Oncologist|February 28, 2021
Comprehensive Review of Molecular Mechanisms and Clinical Features of Invasive Lobular CancerNikhil Pramod, Akanksha Nigam, Mustafa Basree, et al.
The Oncologist|February 19, 2021
Administration Method of Adjuvant Tegafur-Uracil and Leucovorin Calcium in Patients with Resected Colorectal Cancer: A Phase III StudyTaishi Hata, Kiyotaka Hagihara, Anna Tsutsui, et al.
The Oncologist|February 19, 2021
Preemptive Versus Reactive Topical Clobetasol for Regorafenib-Induced Hand-Foot Reactions: A Preplanned Analysis of the ReDOS TrialAminah Jatoi, Fang-Shu Ou, Daniel H Ahn, et al.
The Oncologist|July 27, 2019
Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective StudyEmil Lou, Rachel I Vogel, Spencer Hoostal, et al.
Pageof 571